2015 Volume 29 Issue 2 Pages 122-128
Completion pneumonectomy (CP) for non-small cell lung cancer may be required for local recurrence or second primary lung cancer. We evaluated the CP indications, postoperative complications, and prognosis by retrospectively reviewing 7 men and 2 women, with a mean age of 66.1 (52-77) years, who underwent CP (Jan. 1994 to Dec. 2013). The first primary lung cancer histology included adenocarcinoma (5), squamous cell carcinoma (3), and basaloid carcinoma (1); p-stage IA for 2, p-stage IB for 2, p-stage IIA for 2, and p-stage IIB for 3. Initial surgeries were lobectomy with mediastinal lymph node dissection. CP was performed for second primary lung cancer in 3, and local recurrence in 6. Post-CP complications were cerebral infarction, wound dehiscence, and wound infection (1 patient each). After CP, survival ranged from 2 to 90 months; the actuarial 5-year survival rate was 14.8%. Three of 9 patients survived for>3 years. Generally, CP is difficult, with high postoperative morbidity and mortality rates; however, prolonged survival can result if complications are successfully managed perioperatively. CP is an effective therapeutic method for recurrent or second primary lung cancer.
